{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:48Z","timestamp":1787242308766,"version":"build-2736575974"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiaxing Science and Technology Plan Project","award":["2025CGZ041"],"award-info":[{"award-number":["2025CGZ041"]}]},{"name":"Jiaxing Provincial-Municipal Co-construction Key Discipline in Medicine\u2014Oncology","award":["2023-SSGJ-001"],"award-info":[{"award-number":["2023-SSGJ-001"]}]},{"name":"National Clinical Key Specialty Construction Project\u2014Oncology","award":["2023-GJZK-001"],"award-info":[{"award-number":["2023-GJZK-001"]}]},{"name":"Jiaxing Key Laboratory of Oncology Radiotherapy","award":["2021-zlzdsys"],"award-info":[{"award-number":["2021-zlzdsys"]}]},{"name":"Jiaxing First Hospital Key Project","award":["2025-ZD-002"],"award-info":[{"award-number":["2025-ZD-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04442-8","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:06:10Z","timestamp":1782731170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The microbiota\u2013lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy"],"prefix":"10.1007","volume":"75","author":[{"given":"Yilin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"20","key":"4442_CR1","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1200\/JCO.18.01921","volume":"37","author":"SA Koyfman","year":"2019","unstructured":"Koyfman SA, Ismaila N, Crook D et al (2019) Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline. J Clin Oncol 37(20):1753\u20131774","journal-title":"J Clin Oncol"},{"issue":"1","key":"4442_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01356-7","volume":"15","author":"T Chen","year":"2022","unstructured":"Chen T, Liu Y, Wang Y et al (2022) Evidence-based expert consensus on the management of primary central nervous system lymphoma in China. J Hematol Oncol 15(1):136","journal-title":"J Hematol Oncol"},{"key":"4442_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070754","author":"O Yan","year":"2024","unstructured":"Yan O, Wang S, Wang Q et al (2024) FLASH radiotherapy: mechanisms of biological effects and the therapeutic potential in cancer. Biomolecules. https:\/\/doi.org\/10.3390\/biom14070754","journal-title":"Biomolecules"},{"issue":"1","key":"4442_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","volume":"12","author":"FG Herrera","year":"2022","unstructured":"Herrera FG, Ronet C, de Ochoaolza M et al (2022) Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Discov 12(1):108\u2013133","journal-title":"Cancer Discov"},{"key":"4442_CR5","doi-asserted-by":"publisher","first-page":"175883592513875","DOI":"10.1177\/17588359251387534","volume":"17","author":"X Chen","year":"2025","unstructured":"Chen X, Yang M, Huang Y et al (2025) Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy. Ther Adv Med Oncol 17:17588359251387534","journal-title":"Ther Adv Med Oncol"},{"key":"4442_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803247","volume":"12","author":"M Wu","year":"2021","unstructured":"Wu M, Liu J, Wu S et al (2021) Systemic immune activation and responses of irradiation to different metastatic sites combined with immunotherapy in advanced non-small cell lung cancer. Front Immunol 12:803247","journal-title":"Front Immunol"},{"issue":"8","key":"4442_CR7","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1016\/S1470-2045(19)30401-2","volume":"20","author":"FG Herrera","year":"2019","unstructured":"Herrera FG, Irving M, Kandalaft LE et al (2019) Rational combinations of immunotherapy with radiotherapy in ovarian cancer. Lancet Oncol 20(8):e417\u2013e433","journal-title":"Lancet Oncol"},{"issue":"3","key":"4442_CR8","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.7150\/thno.90376","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Akhil V, Seo HS et al (2024) The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy. Theranostics 14(3):1195\u20131211","journal-title":"Theranostics"},{"issue":"9","key":"4442_CR9","doi-asserted-by":"publisher","first-page":"e012211","DOI":"10.1136\/jitc-2025-012211","volume":"13","author":"S Lakshmanachetty","year":"2025","unstructured":"Lakshmanachetty S, Riemondy K, Sanford B et al (2025) Differential phagocytosis induces diverse macrophage activation states in malignant gliomas. J Immunother Cancer 13(9):e012211","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4442_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-025-02366-y","volume":"24","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Liu M, Wang Z et al (2025) Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy. Mol Cancer 24(1):176","journal-title":"Mol Cancer"},{"issue":"13","key":"4442_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202419418","volume":"37","author":"S Deng","year":"2025","unstructured":"Deng S, Hu L, Chen G et al (2025) A PD-L1 siRNA-loaded boron nanoparticle for targeted cancer radiotherapy and immunotherapy. Adv Mater 37(13):e2419418","journal-title":"Adv Mater"},{"issue":"8","key":"4442_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41571-023-00782-x","volume":"20","author":"L Galluzzi","year":"2023","unstructured":"Galluzzi L, Aryankalayil MJ, Coleman CN et al (2023) Emerging evidence for adapting radiotherapy to immunotherapy. Nat Rev Clin Oncol 20(8):543\u2013557","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"4442_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJMoa1112824","volume":"366","author":"MA Postow","year":"2012","unstructured":"Postow MA, Callahan MK, Barker CA et al (2012) Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366(10):925\u2013931","journal-title":"N Engl J Med"},{"issue":"2","key":"4442_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijrobp.2012.03.017","volume":"85","author":"EF Stamell","year":"2013","unstructured":"Stamell EF, Wolchok JD, Gnjatic S et al (2013) The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys 85(2):293\u2013295","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"4442_CR15","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","volume":"24","author":"SC Formenti","year":"2018","unstructured":"Formenti SC, Rudqvist NP, Golden E et al (2018) Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med 24(12):1845\u20131851","journal-title":"Nat Med"},{"issue":"5","key":"4442_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jtho.2020.12.015","volume":"16","author":"C Faivre-Finn","year":"2021","unstructured":"Faivre-Finn C, Vicente D, Kurata T et al (2021) Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial. J Thorac Oncol 16(5):860\u2013867","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4442_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1470-2045(21)00630-6","volume":"23","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Chen M, Jiang O et al (2022) Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial. Lancet Oncol 23(2):209\u2013219","journal-title":"Lancet Oncol"},{"issue":"6","key":"4442_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S1470-2045(21)00149-2","volume":"22","author":"NK Altorki","year":"2021","unstructured":"Altorki NK, McGraw TE, Borczuk AC et al (2021) Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial. Lancet Oncol 22(6):824\u2013835","journal-title":"Lancet Oncol"},{"issue":"1","key":"4442_CR19","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.1038\/s41467-023-44195-x","volume":"14","author":"NK Altorki","year":"2023","unstructured":"Altorki NK, Walsh ZH, Melms JC et al (2023) Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nat Commun 14(1):8435","journal-title":"Nat Commun"},{"issue":"1","key":"4442_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","volume":"8","author":"KB Pointer","year":"2022","unstructured":"Pointer KB, Pitroda SP, Weichselbaum RR (2022) Radiotherapy and immunotherapy: open questions and future strategies. Trends Cancer 8(1):9\u201320","journal-title":"Trends Cancer"},{"issue":"1","key":"4442_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1470-2045(24)00573-4","volume":"26","author":"JH Heinzerling","year":"2025","unstructured":"Heinzerling JH, Mileham KF, Robinson MM et al (2025) Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial. Lancet Oncol 26(1):85\u201397","journal-title":"Lancet Oncol"},{"issue":"2","key":"4442_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S2468-1253(22)00339-9","volume":"8","author":"CL Chiang","year":"2023","unstructured":"Chiang CL, Chiu KWH, Chan KSK et al (2023) Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial. Lancet Gastroenterol Hepatol 8(2):169\u2013178","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"4442_CR23","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","volume":"2","author":"AR Parikh","year":"2021","unstructured":"Parikh AR, Szabolcs A, Allen JN et al (2021) Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat Cancer 2(11):1124\u20131135","journal-title":"Nat Cancer"},{"issue":"1","key":"4442_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/neuonc\/noac099","volume":"25","author":"A Omuro","year":"2023","unstructured":"Omuro A, Brandes AA, Carpentier AF et al (2023) Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial. Neuro Oncol 25(1):123\u2013134","journal-title":"Neuro Oncol"},{"issue":"33","key":"4442_CR25","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1200\/JCO-25-00036","volume":"43","author":"JD Bradley","year":"2025","unstructured":"Bradley JD, Sugawara S, Lee KH et al (2025) Simultaneous durvalumab and platinum-based chemoradiotherapy in unresectable stage III non-small cell lung cancer: the phase III PACIFIC-2 study. J Clin Oncol 43(33):3610\u20133621","journal-title":"J Clin Oncol"},{"issue":"10405","key":"4442_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","volume":"402","author":"JY Chang","year":"2023","unstructured":"Chang JY, Lin SH, Dong W et al (2023) Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet 402(10405):871\u2013881","journal-title":"Lancet"},{"issue":"3","key":"4442_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.radonc.2018.05.017","volume":"128","author":"JA Contreras","year":"2018","unstructured":"Contreras JA, Lin AJ, Weiner A et al (2018) Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer. Radiother Oncol 128(3):498\u2013504","journal-title":"Radiother Oncol"},{"issue":"8072","key":"4442_CR28","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-025-08994-0","volume":"643","author":"A PIFFK\u00f3","year":"2025","unstructured":"PIFFK\u00f3 A, Yang K, Panda A et al (2025) Radiation-induced amphiregulin drives tumour metastasis. Nature 643(8072):810\u2013819","journal-title":"Nature"},{"issue":"2","key":"4442_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","volume":"30","author":"P Lambin","year":"2020","unstructured":"Lambin P, Lieverse RIY, Eckert F et al (2020) Lymphocyte-sparing radiotherapy: the rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy. Semin Radiat Oncol 30(2):187\u2013193","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"4442_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijrobp.2024.12.014","volume":"122","author":"PJJ Damen","year":"2025","unstructured":"Damen PJJ, Peters M, Hobbs B et al (2025) Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer. Int J Radiat Oncol Biol Phys 122(1):31\u201342","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4442_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","volume":"111","author":"PJJ Damen","year":"2021","unstructured":"Damen PJJ, Kroese TE, VAN Hillegersberg R et al (2021) The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 111(4):936\u2013948","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"4442_CR32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","volume":"15","author":"A Abravan","year":"2020","unstructured":"Abravan A, Faivre-Finn C, Kennedy J et al (2020) Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer. J Thorac Oncol 15(10):1624\u20131635","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4442_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.101038","volume":"8","author":"Y el Houat","year":"2023","unstructured":"el Houat Y, Massard C, Quillien V et al (2023) Meta-analysis and critical review: association between radio-induced lymphopenia and overall survival in solid cancers. Adv Radiat Oncol 8(2):101038","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"4442_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ijc.31744","volume":"144","author":"Z Yin","year":"2019","unstructured":"Yin Z, Li C, Wang J et al (2019) Myeloid-derived suppressor cells: roles in the tumor microenvironment and tumor radiotherapy. Int J Cancer 144(5):933\u2013946","journal-title":"Int J Cancer"},{"issue":"1","key":"4442_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S et al (2021) Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med 27(1):152\u2013164","journal-title":"Nat Med"},{"issue":"7","key":"4442_CR36","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1136\/jitc-2022-004784","volume":"10","author":"J Ye","year":"2022","unstructured":"Ye J, Mills BN, Qin SS et al (2022) Toll-like receptor 7\/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. J Immunother Cancer 10(7):4784","journal-title":"J Immunother Cancer"},{"issue":"6","key":"4442_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk1827","volume":"10","author":"J Wang","year":"2024","unstructured":"Wang J, Gai J, Zhang T et al (2024) Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells. Sci Adv 10(6):eadk1827","journal-title":"Sci Adv"},{"issue":"1","key":"4442_CR38","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1038\/s41467-019-11906-2","volume":"10","author":"A Arina","year":"2019","unstructured":"Arina A, Beckett M, Fernandez C et al (2019) Tumor-reprogrammed resident T cells resist radiation to control tumors. Nat Commun 10(1):3959","journal-title":"Nat Commun"},{"issue":"2","key":"4442_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4161\/cbt.6.2.3627","volume":"6","author":"S Toden","year":"2007","unstructured":"Toden S, Bird AR, Topping DL et al (2007) Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids. Cancer Biol Ther 6(2):253\u2013258","journal-title":"Cancer Biol Ther"},{"key":"4442_CR40","doi-asserted-by":"publisher","first-page":"1190810","DOI":"10.3389\/fimmu.2023.1190810","volume":"14","author":"C Mowat","year":"2023","unstructured":"Mowat C, Dhatt J, Bhatti I et al (2023) Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity. Front Immunol 14:1190810","journal-title":"Front Immunol"},{"key":"4442_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2024.100593","volume":"30","author":"Z Nowicka","year":"2024","unstructured":"Nowicka Z, Kuna K, \u0141aszczych M et al (2024) Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniques. Phys Imaging Radiat Oncol 30:100593","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"1","key":"4442_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13014-020-01494-7","volume":"15","author":"X Xie","year":"2020","unstructured":"Xie X, Gong S, Jin H et al (2020) Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count. Radiat Oncol 15(1):65","journal-title":"Radiat Oncol"},{"issue":"1","key":"4442_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s40425-019-0718-6","volume":"7","author":"H Menon","year":"2019","unstructured":"Menon H, Chen D, Ramapriyan R et al (2019) Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer 7(1):237","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4442_CR44","doi-asserted-by":"publisher","first-page":"22949","DOI":"10.1038\/s41598-024-74397-2","volume":"14","author":"W Duan","year":"2024","unstructured":"Duan W, Wu H, Zhu Y et al (2024) Dosimetric comparison of gamma knife and linear accelerator (VMAT and IMRT) plans of SBRT of Lung tumours. Sci Rep 14(1):22949","journal-title":"Sci Rep"},{"issue":"3","key":"4442_CR45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","volume":"94","author":"AT Wild","year":"2016","unstructured":"Wild AT, Herman JM, Dholakia AS et al (2016) Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 94(3):571\u2013579","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4442_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijrobp.2022.12.030","volume":"116","author":"Y Li","year":"2023","unstructured":"Li Y, Fan X, Yu Q et al (2023) Proton and carbon ion radiation therapy decreased severe lymphopenia by reducing thoracic vertebra and aortic doses in non-small cell lung cancer versus intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 116(3):579\u2013589","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"4442_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2023.101260","volume":"8","author":"J Zhang","year":"2023","unstructured":"Zhang J, Yang L, Li H et al (2023) Dosimetric effect of thymus and thoracic duct on radiation-induced lymphopenia in patients with primary lung cancer who received thoracic radiation. Adv Radiat Oncol 8(6):101260","journal-title":"Adv Radiat Oncol"},{"issue":"8","key":"4442_CR48","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1097\/JS9.0000000000001546","volume":"110","author":"J Meng","year":"2024","unstructured":"Meng J, Yang Y, Lv J et al (2024) CXCR6 expression correlates with radiotherapy response and immune context in triple-negative breast cancer-experimental studies. Int J Surg 110(8):4695\u20134707","journal-title":"Int J Surg"},{"issue":"7","key":"4442_CR49","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.trecan.2021.01.010","volume":"7","author":"CB Zhou","year":"2021","unstructured":"Zhou CB, Zhou YL, Fang JY (2021) Gut microbiota in cancer immune response and immunotherapy. Trends Cancer 7(7):647\u2013660","journal-title":"Trends Cancer"},{"issue":"2","key":"4442_CR50","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1053\/j.gastro.2020.11.041","volume":"160","author":"V Matson","year":"2021","unstructured":"Matson V, Chervin CS, Gajewski TF (2021) Cancer and the microbiome-influence of the commensal microbiota on cancer, immune responses, and immunotherapy. Gastroenterology 160(2):600\u2013613","journal-title":"Gastroenterology"},{"issue":"24","key":"4442_CR51","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1001\/jama.2025.2191","volume":"333","author":"E Fernandez","year":"2025","unstructured":"Fernandez E, Wargo JA, Helmink BA (2025) The microbiome and cancer: a translational science review. JAMA 333(24):2188\u20132196","journal-title":"JAMA"},{"issue":"1","key":"4442_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","volume":"7","author":"J Fessler","year":"2019","unstructured":"Fessler J, Matson V, Gajewski TF (2019) Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer 7(1):108","journal-title":"J Immunother Cancer"},{"issue":"2","key":"4442_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwad044","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang W, Cui B, Nie Y et al (2024) Radiation injury and gut microbiota-based treatment. Protein Cell 15(2):83\u201397","journal-title":"Protein Cell"},{"issue":"1","key":"4442_CR54","doi-asserted-by":"publisher","first-page":"2528429","DOI":"10.1080\/19490976.2025.2528429","volume":"17","author":"L Li","year":"2025","unstructured":"Li L, Yang Z, Yi Y et al (2025) Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies. Gut Microbes 17(1):2528429","journal-title":"Gut Microbes"},{"key":"4442_CR55","doi-asserted-by":"publisher","first-page":"1459206","DOI":"10.3389\/fimmu.2024.1459206","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Chen Q, Liu Z et al (2024) Predictive value of bowel dose-volume for severe radiation-induced lymphopenia and survival in cervical cancer. Front Immunol 15:1459206","journal-title":"Front Immunol"},{"issue":"3","key":"4442_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","volume":"45","author":"M Bemark","year":"2024","unstructured":"Bemark M, Pitcher MJ, Dionisi C et al (2024) Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends Immunol 45(3):211\u2013223","journal-title":"Trends Immunol"},{"issue":"7","key":"4442_CR57","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2025.06.021","volume":"169","author":"MF DU PR\u00e9","year":"2025","unstructured":"DU PR\u00e9 MF, Kleppa L, Dewan AE et al (2025) Peyer\u2019s patch B cells sample transglutaminase-gluten complexes and drive celiac disease autoimmunity. Gastroenterology 169(7):1450\u20131461","journal-title":"Gastroenterology"},{"issue":"3","key":"4442_CR58","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2020.02.001","volume":"52","author":"TM Fenton","year":"2020","unstructured":"Fenton TM, J\u00f8RGENSEN PB, Niss K et al (2020) Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in priming of region-specific immunity. Immunity 52(3):557\u201370.e6","journal-title":"Immunity"},{"issue":"2","key":"4442_CR59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ijrobp.2025.03.080","volume":"123","author":"C Beekman","year":"2025","unstructured":"Beekman C, Carrasco-Rojas N, Withrow J et al (2025) Radiation-induced lymphopenia: in silico replications of preclinical studies suggest importance of dose to lymphoid organs. Int J Radiat Oncol Biol Phys 123(2):550\u2013562","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10434","key":"4442_CR60","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","volume":"403","author":"D Lorusso","year":"2024","unstructured":"Lorusso D, Xiang Y, Hasegawa K et al (2024) Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial. Lancet 403(10434):1341\u20131350","journal-title":"Lancet"},{"issue":"10460","key":"4442_CR61","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"D Lorusso","year":"2024","unstructured":"Lorusso D, Xiang Y, Hasegawa K et al (2024) Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 404(10460):1321\u20131332","journal-title":"Lancet"},{"issue":"28","key":"4442_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306217","volume":"11","author":"Z Ge","year":"2024","unstructured":"Ge Z, Chen C, Chen J et al (2024) Gut microbiota-derived 3-hydroxybutyrate blocks GPR43-mediated IL6 signaling to ameliorate radiation proctopathy. Adv Sci (Weinh) 11(28):e2306217","journal-title":"Adv Sci (Weinh)"},{"key":"4442_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.586392","volume":"11","author":"Y Jian","year":"2021","unstructured":"Jian Y, Zhang D, Liu M et al (2021) The impact of gut microbiota on radiation-induced enteritis. Front Cell Infect Microbiol 11:586392","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4442_CR64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13014-021-01899-y","volume":"16","author":"L Wang","year":"2021","unstructured":"Wang L, Wang X, Zhang G et al (2021) The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review. Radiat Oncol 16(1):187","journal-title":"Radiat Oncol"},{"issue":"1","key":"4442_CR65","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijrobp.2024.03.003","volume":"120","author":"LW Xie","year":"2024","unstructured":"Xie LW, Lu HY, Tang LF et al (2024) Probiotic consortia protect the intestine against radiation injury by improving intestinal epithelial homeostasis. Int J Radiat Oncol Biol Phys 120(1):189\u2013204","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"4442_CR66","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3727\/096368916X691664","volume":"25","author":"L Moussa","year":"2016","unstructured":"Moussa L, Usunier B, Demarquay C et al (2016) Bowel radiation injury: complexity of the pathophysiology and promises of cell and tissue engineering. Cell Transplant 25(10):1723\u20131746","journal-title":"Cell Transplant"},{"key":"4442_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103226","volume":"159","author":"MI Koukourakis","year":"2021","unstructured":"Koukourakis MI, Giatromanolaki A (2021) Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy. Crit Rev Oncol Hematol 159:103226","journal-title":"Crit Rev Oncol Hematol"},{"key":"4442_CR68","doi-asserted-by":"publisher","first-page":"1151250","DOI":"10.3389\/fimmu.2023.1151250","volume":"14","author":"S Yamaga","year":"2023","unstructured":"Yamaga S, Murao A, Ma G et al (2023) Radiation upregulates macrophage TREM-1 expression to exacerbate injury in mice. Front Immunol 14:1151250","journal-title":"Front Immunol"},{"issue":"14","key":"4442_CR69","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1182\/blood.2022017514","volume":"141","author":"X Zeng","year":"2023","unstructured":"Zeng X, Li X, Li X et al (2023) Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation. Blood 141(14):1691\u20131707","journal-title":"Blood"},{"issue":"1","key":"4442_CR70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ajt.15501","volume":"20","author":"J Zheng","year":"2020","unstructured":"Zheng J, Taylor B, Dodge J et al (2020) Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation. Am J Transplant 20(1):64\u201374","journal-title":"Am J Transplant"},{"key":"4442_CR71","doi-asserted-by":"publisher","first-page":"1338178","DOI":"10.3389\/fimmu.2024.1338178","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang H, Shi G et al (2024) The impact of gut microbial signals on hematopoietic stem cells and the bone marrow microenvironment. Front Immunol 15:1338178","journal-title":"Front Immunol"},{"issue":"9","key":"4442_CR72","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s12276-021-00667-y","volume":"53","author":"YS Lee","year":"2021","unstructured":"Lee YS, Kim TY, Kim Y et al (2021) Microbiota-derived lactate promotes hematopoiesis and erythropoiesis by inducing stem cell factor production from leptin receptor+ niche cells. Exp Mol Med 53(9):1319\u20131331","journal-title":"Exp Mol Med"},{"issue":"2","key":"4442_CR73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1182\/blood-2016-06-723742","volume":"129","author":"C Iwamura","year":"2017","unstructured":"Iwamura C, Bouladoux N, Belkaid Y et al (2017) Sensing of the microbiota by NOD1 in mesenchymal stromal cells regulates murine hematopoiesis. Blood 129(2):171\u2013176","journal-title":"Blood"},{"issue":"18","key":"4442_CR74","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1158\/1078-0432.CCR-23-3860","volume":"30","author":"A Teijeira","year":"2024","unstructured":"Teijeira A, Garasa S, Ochoa MC et al (2024) Low-dose Ionizing \u03b3-radiation elicits the extrusion of neutrophil extracellular traps. Clin Cancer Res 30(18):4131\u20134142","journal-title":"Clin Cancer Res"},{"issue":"20","key":"4442_CR75","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1182\/blood-2013-07-515619","volume":"123","author":"L Shao","year":"2014","unstructured":"Shao L, Feng W, Li H et al (2014) Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner. Blood 123(20):3105\u20133115","journal-title":"Blood"},{"key":"4442_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2025.104792","volume":"147","author":"S Kosanovic","year":"2025","unstructured":"Kosanovic S, Vanickova K, Milosevic M et al (2025) Distinct transcriptional changes in hematopoietic progenitor subsets on LPS-induced emergency granulopoiesis. Exp Hematol 147:104792","journal-title":"Exp Hematol"},{"issue":"1","key":"4442_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1182\/blood.2021011570","volume":"139","author":"LV Kovtonyuk","year":"2022","unstructured":"Kovtonyuk LV, Caiado F, Garcia-Martin S et al (2022) IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood 139(1):44\u201358","journal-title":"Blood"},{"issue":"2","key":"4442_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202509383","volume":"13","author":"H Zhu","year":"2026","unstructured":"Zhu H, Guo H, Sun N et al (2026) Faecalibaculum rodentium alleviates ionizing radiation-induced damage in mice by improving intestinal integrity and hematopoiesis via its metabolite butyrate. Adv Sci (Weinh) 13(2):e09383","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"4442_CR79","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.stem.2021.12.009","volume":"29","author":"D Zhang","year":"2022","unstructured":"Zhang D, Gao X, Li H et al (2022) The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow. Cell Stem Cell 29(2):232\u201347.e7","journal-title":"Cell Stem Cell"},{"issue":"5","key":"4442_CR80","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41577-023-00951-0","volume":"24","author":"SJ Blake","year":"2024","unstructured":"Blake SJ, Wolf Y, Boursi B et al (2024) Role of the microbiota in response to and recovery from cancer therapy. Nat Rev Immunol 24(5):308\u2013325","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4442_CR81","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41571-025-01052-8","volume":"22","author":"J Chen","year":"2025","unstructured":"Chen J, Deutsch E, Kroemer G et al (2025) The microbiota in radiotherapy-induced cancer immunosurveillance. Nat Rev Clin Oncol 22(9):667\u2013679","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"4442_CR82","doi-asserted-by":"publisher","first-page":"BSR20202993","DOI":"10.1042\/BSR20202993","volume":"41","author":"S Zhu","year":"2021","unstructured":"Zhu S, Liang J, Zhu F et al (2021) The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice. Biosci Rep 41(3):BSR20202993","journal-title":"Biosci Rep"},{"issue":"2","key":"4442_CR83","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11010-023-04732-0","volume":"479","author":"D Guan","year":"2024","unstructured":"Guan D, Yang Y, Pang M et al (2024) Indole-3-carboxaldehyde ameliorates ionizing radiation-induced hematopoietic injury by enhancing hematopoietic stem and progenitor cell quiescence. Mol Cell Biochem 479(2):313\u2013323","journal-title":"Mol Cell Biochem"},{"key":"4442_CR84","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13578-019-0286-y","volume":"9","author":"JG Kiang","year":"2019","unstructured":"Kiang JG, Olabisi AO (2019) Radiation: a poly-traumatic hit leading to multi-organ injury. Cell Biosci 9:25","journal-title":"Cell Biosci"},{"issue":"5","key":"4442_CR85","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/mco2.388","volume":"4","author":"J Tan","year":"2023","unstructured":"Tan J, Sun X, Zhao H et al (2023) (2020) Double-strand DNA break repair: molecular mechanisms and therapeutic targets. MedComm (2020) 4(5):388","journal-title":"MedComm (2020)"},{"key":"4442_CR86","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.2147\/JIR.S369385","volume":"15","author":"YY Yang","year":"2022","unstructured":"Yang YY, Liu J, Liu YT et al (2022) Moderate dose irradiation induces DNA damage and impairments of barrier and host defense in nasal epithelial cells in vitro. J Inflamm Res 15:3661\u20133675","journal-title":"J Inflamm Res"},{"issue":"6516","key":"4442_CR87","doi-asserted-by":"publisher","first-page":"eaay9097","DOI":"10.1126\/science.aay9097","volume":"370","author":"H Guo","year":"2020","unstructured":"Guo H, Chou WC, Lai Y et al (2020) Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science 370(6516):eaay9097","journal-title":"Science"},{"issue":"1","key":"4442_CR88","doi-asserted-by":"publisher","first-page":"2393270","DOI":"10.1080\/19490976.2024.2393270","volume":"16","author":"KE Hays","year":"2024","unstructured":"Hays KE, Pfaffinger JM, Ryznar R (2024) The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. Gut Microbes 16(1):2393270","journal-title":"Gut Microbes"},{"issue":"10","key":"4442_CR89","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang X, Fang Y, Liang W et al (2024) Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell 42(10):1729\u201346.e8","journal-title":"Cancer Cell"},{"issue":"1","key":"4442_CR90","doi-asserted-by":"publisher","first-page":"1968257","DOI":"10.1080\/19490976.2021.1968257","volume":"13","author":"G Li","year":"2021","unstructured":"Li G, Lin J, Zhang C et al (2021) Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes 13(1):1968257","journal-title":"Gut Microbes"},{"issue":"1","key":"4442_CR91","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A et al (2021) Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun 12(1):4077","journal-title":"Nat Commun"},{"key":"4442_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011047","author":"D Averbeck","year":"2021","unstructured":"Averbeck D, Rodriguez-Lafrasse C (2021) Role of mitochondria in radiation responses: epigenetic, metabolic, and signaling impacts. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222011047","journal-title":"Int J Mol Sci"},{"key":"4442_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103746","volume":"85","author":"H Wu","year":"2025","unstructured":"Wu H, Li YL, Wang Y et al (2025) Anemoside B4 alleviates ulcerative colitis by attenuating intestinal oxidative stress and NLRP3 inflammasome via activating aryl hydrocarbon receptor through remodeling the gut microbiome and metabolites. Redox Biol 85:103746","journal-title":"Redox Biol"},{"key":"4442_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111852","volume":"131","author":"L Zhang","year":"2024","unstructured":"Zhang L, Ma Z, Zhang X et al (2024) Butyrate alleviates alcoholic liver disease-associated inflammation through macrophage regulation and polarization via the HDAC1\/miR-155 axis. Int Immunopharmacol 131:111852","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4442_CR95","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW et al (2015) The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21(3):263\u2013269","journal-title":"Nat Med"},{"issue":"1","key":"4442_CR96","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41398-017-0089-z","volume":"8","author":"S Rose","year":"2018","unstructured":"Rose S, Bennuri SC, Davis JE et al (2018) Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Transl Psychiatry 8(1):42","journal-title":"Transl Psychiatry"},{"issue":"3","key":"4442_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113846","volume":"43","author":"J Dong","year":"2024","unstructured":"Dong J, Wang B, Xiao Y et al (2024) Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate\/OR51E1\/RALB axis. Cell Rep 43(3):113846","journal-title":"Cell Rep"},{"issue":"3","key":"4442_CR98","doi-asserted-by":"publisher","first-page":"e20201915","DOI":"10.1084\/jem.20201915","volume":"218","author":"K Yang","year":"2021","unstructured":"Yang K, Hou Y, Zhang Y et al (2021) Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation. J Exp Med 218(3):e20201915","journal-title":"J Exp Med"},{"issue":"7610","key":"4442_CR99","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","volume":"535","author":"K Honda","year":"2016","unstructured":"Honda K, Littman DR (2016) The microbiota in adaptive immune homeostasis and disease. Nature 535(7610):75\u201384","journal-title":"Nature"},{"issue":"1","key":"4442_CR100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","volume":"8","author":"J Park","year":"2015","unstructured":"Park J, Kim M, Kang SG et al (2015) Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8(1):80\u201393","journal-title":"Mucosal Immunol"},{"issue":"2","key":"4442_CR101","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","volume":"145","author":"MH Kim","year":"2013","unstructured":"Kim MH, Kang SG, Park JH et al (2013) Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145(2):396-406.e1-10","journal-title":"Gastroenterology"},{"issue":"1","key":"4442_CR102","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41522-025-00698-7","volume":"11","author":"D Gao","year":"2025","unstructured":"Gao D, Zhuang Y, Liu S et al (2025) Multi-omics profiling of dairy cattle oxidative stress identifies hindgut-derived Phascolarctobacterium succinatutens exhibiting antioxidant activity. NPJ Biofilms Microbiomes 11(1):61","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"4442_CR103","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1038\/s41598-023-40130-8","volume":"13","author":"E Buchanan","year":"2023","unstructured":"Buchanan E, Mahony C, Bam S et al (2023) Propionic acid induces alterations in mitochondrial morphology and dynamics in SH-SY5Y cells. Sci Rep 13(1):13248","journal-title":"Sci Rep"},{"issue":"1","key":"4442_CR104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40168-024-02001-w","volume":"13","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C, Yuan B et al (2025) Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer\u2019s disease pathologic process via GPR41 and GPR43. Microbiome 13(1):16","journal-title":"Microbiome"},{"key":"4442_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050488","author":"PH Reddy","year":"2019","unstructured":"Reddy PH, Oliver DM (2019) Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in alzheimer\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells8050488","journal-title":"Cells"},{"issue":"22","key":"4442_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70366","volume":"13","author":"NG Kanter","year":"2024","unstructured":"Kanter NG, Cohen-Woods S, Balfour DA et al (2024) Hypothalamic-pituitary-adrenal axis dysfunction in people with cancer: a systematic review. Cancer Med 13(22):e70366","journal-title":"Cancer Med"},{"issue":"7","key":"4442_CR107","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10571-012-9843-1","volume":"32","author":"N Veli\u010dkovi\u0107","year":"2012","unstructured":"Veli\u010dkovi\u0107 N, Drakuli\u0107 D, Petrovi\u0107 S et al (2012) Time-course of hypothalamic-pituitary-adrenal axis activity and inflammation in juvenile rat brain after cranial irradiation. Cell Mol Neurobiol 32(7):1175\u20131185","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"4442_CR108","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cmet.2024.10.003","volume":"37","author":"GSS Tofani","year":"2025","unstructured":"Tofani GSS, Leigh SJ, Gheorghe CE et al (2025) Gut microbiota regulates stress responsivity via the circadian system. Cell Metab 37(1):138\u201353.e5","journal-title":"Cell Metab"},{"issue":"7676","key":"4442_CR109","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou Z, Ghosh K, Vizioli MG et al (2017) Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550(7676):402\u2013406","journal-title":"Nature"},{"issue":"7361","key":"4442_CR110","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nature10287","volume":"476","author":"JS Snyder","year":"2011","unstructured":"Snyder JS, Soumier A, Brewer M et al (2011) Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476(7361):458\u2013461","journal-title":"Nature"},{"key":"4442_CR111","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1475-2867-14-35","volume":"14","author":"AL Miller","year":"2014","unstructured":"Miller AL, Geng C, Golovko G et al (2014) Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells. Cancer Cell Int 14:35","journal-title":"Cancer Cell Int"},{"issue":"Suppl 1","key":"4442_CR112","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"Schmidt S, Rainer J, Ploner C et al (2004) Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 11(Suppl 1):S45-55","journal-title":"Cell Death Differ"},{"issue":"5","key":"4442_CR113","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.stem.2025.02.016","volume":"32","author":"G Zhang","year":"2025","unstructured":"Zhang G, Lian Y, Li Q et al (2025) Vagal pathway activation links chronic stress to decline in intestinal stem cell function. Cell Stem Cell 32(5):778\u201394.e10","journal-title":"Cell Stem Cell"},{"issue":"38","key":"4442_CR114","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV et al (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108(38):16050\u201316055","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"4442_CR115","doi-asserted-by":"publisher","first-page":"a034199","DOI":"10.1101\/cshperspect.a034199","volume":"9","author":"B Bonaz","year":"2019","unstructured":"Bonaz B, Sinniger V, Pellissier S (2019) Vagus nerve stimulation at the interface of brain-gut interactions. Cold Spring Harb Perspect Med 9(8):a034199","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4442_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00489","volume":"7","author":"R Huo","year":"2017","unstructured":"Huo R, Zeng B, Zeng L et al (2017) Microbiota modulate anxiety-like behavior and endocrine abnormalities in hypothalamic-pituitary-adrenal axis. Front Cell Infect Microbiol 7:489","journal-title":"Front Cell Infect Microbiol"},{"key":"4442_CR117","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbi.2018.07.007","volume":"73","author":"M Vodi\u010dka","year":"2018","unstructured":"Vodi\u010dka M, Ergang P, HRN\u010c\u00ed\u0158 T et al (2018) Microbiota affects the expression of genes involved in HPA axis regulation and local metabolism of glucocorticoids in chronic psychosocial stress. Brain Behav Immun 73:615\u2013624","journal-title":"Brain Behav Immun"},{"issue":"1","key":"4442_CR118","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13311-017-0600-5","volume":"15","author":"A Farzi","year":"2018","unstructured":"Farzi A, FR\u00f6HLICH EE, Holzer P (2018) Gut microbiota and the neuroendocrine system. Neurotherapeutics 15(1):5\u201322","journal-title":"Neurotherapeutics"},{"issue":"5","key":"4442_CR119","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/19490976.2020.1758008","volume":"11","author":"N Ma","year":"2020","unstructured":"Ma N, He T, Johnston LJ et al (2020) Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling. Gut Microbes 11(5):1203\u20131219","journal-title":"Gut Microbes"},{"issue":"3","key":"4442_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00109-023-02289-5","volume":"101","author":"A Salminen","year":"2023","unstructured":"Salminen A (2023) Activation of aryl hydrocarbon receptor (AhR) in Alzheimer\u2019s disease: role of tryptophan metabolites generated by gut host-microbiota. J Mol Med (Berl) 101(3):201\u2013222","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"4442_CR121","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/nu16071054","volume":"16","author":"A Dziedzic","year":"2024","unstructured":"Dziedzic A, Maciak K, Bli\u017aniewska-Kowalska K et al (2024) The power of psychobiotics in depression: a modern approach through the microbiota-gut-brain axis: a literature review. Nutrients 16(7):1054","journal-title":"Nutrients"},{"issue":"6","key":"4442_CR122","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23(6):716\u2013724","journal-title":"Cell Host Microbe"},{"issue":"1","key":"4442_CR123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40168-018-0439-y","volume":"6","author":"L Hoyles","year":"2018","unstructured":"Hoyles L, Snelling T, Umlai UK et al (2018) Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome 6(1):55","journal-title":"Microbiome"},{"issue":"2","key":"4442_CR124","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","volume":"1863","author":"SM Ahmed","year":"2017","unstructured":"Ahmed SM, Luo L, Namani A et al (2017) Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis 1863(2):585\u2013597","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"4442_CR125","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD (2025) Thirty years of NRF2: advances and therapeutic challenges. Nat Rev Drug Discov 24(6):421\u2013444","journal-title":"Nat Rev Drug Discov"},{"issue":"263","key":"4442_CR126","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V, Al-Asmakh M, Kowal C et al (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6(263):263ra158","journal-title":"Sci Transl Med"},{"key":"4442_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.796288","volume":"13","author":"Y Mou","year":"2022","unstructured":"Mou Y, Du Y, Zhou L et al (2022) Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging. Front Immunol 13:796288","journal-title":"Front Immunol"},{"key":"4442_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/nu16203564","author":"M Jain","year":"2024","unstructured":"Jain M, Anand A, Sharma N et al (2024) Effect of probiotics supplementation on cortisol levels: a systematic review and meta-analysis. Nutrients. https:\/\/doi.org\/10.3390\/nu16203564","journal-title":"Nutrients"},{"issue":"7","key":"4442_CR129","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1016\/j.clon.2023.04.003","volume":"35","author":"C Terrones-Campos","year":"2023","unstructured":"Terrones-Campos C, Ledergerber B, Forbes N et al (2023) Prediction of radiation-induced lymphopenia following exposure of the thoracic region and associated risk of infections and mortality. Clin Oncol (R Coll Radiol) 35(7):e434\u2013e444","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4442_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1426635","volume":"15","author":"\u0141 Kuncman","year":"2024","unstructured":"Kuncman \u0141, Pajdzi\u0144ski M, SM\u00f3\u0141KA K et al (2024) Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer. Front Immunol 15:1426635","journal-title":"Front Immunol"},{"issue":"1","key":"4442_CR131","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13014-020-01735-9","volume":"16","author":"J Liu","year":"2021","unstructured":"Liu J, Liu C, Yue J (2021) Radiotherapy and the gut microbiome: facts and fiction. Radiat Oncol 16(1):9","journal-title":"Radiat Oncol"},{"key":"4442_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111009","volume":"210","author":"BMF Cheung","year":"2025","unstructured":"Cheung BMF, Yuen KK, Luk MY et al (2025) Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: establishment of organs-at-risk constraints. Radiother Oncol 210:111009","journal-title":"Radiother Oncol"},{"issue":"6","key":"4442_CR133","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/mp.17829","volume":"52","author":"J Li","year":"2025","unstructured":"Li J, Mali R, Gan GN et al (2025) Patient-specific modeling of radiation-induced lymphopenia for head and neck cancer. Med Phys 52(6):3583\u20133594","journal-title":"Med Phys"},{"key":"4442_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1066255","volume":"14","author":"J Qiu","year":"2023","unstructured":"Qiu J, Lin H, Ke D et al (2023) Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma. Front Immunol 14:1066255","journal-title":"Front Immunol"},{"key":"4442_CR135","doi-asserted-by":"publisher","first-page":"1119173","DOI":"10.3389\/fonc.2023.1119173","volume":"13","author":"N Kim","year":"2023","unstructured":"Kim N, Shin J, Ahn SH et al (2023) Reduced radiation exposure to circulating blood cells in proton therapy compared with x-ray therapy in locally advanced lung cancer: computational simulation based on circulating blood cells. Front Oncol 13:1119173","journal-title":"Front Oncol"},{"issue":"1","key":"4442_CR136","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-024-00211-0","volume":"5","author":"SM Chen","year":"2024","unstructured":"Chen SM, Guo BJ, Feng AQ et al (2024) Pathways regulating intestinal stem cells and potential therapeutic targets for radiation enteropathy. Mol Biomed 5(1):46","journal-title":"Mol Biomed"},{"issue":"8","key":"4442_CR137","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrgastro.2014.46","volume":"11","author":"M Hauer-Jensen","year":"2014","unstructured":"Hauer-Jensen M, Denham JW, Andreyev HJ (2014) Radiation enteropathy--pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol 11(8):470\u2013479","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4442_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101405","author":"T Kumagai","year":"2018","unstructured":"Kumagai T, Rahman F, Smith AM (2018) The microbiome and radiation induced-bowel injury: evidence for potential mechanistic role in disease pathogenesis. Nutrients. https:\/\/doi.org\/10.3390\/nu10101405","journal-title":"Nutrients"},{"issue":"6","key":"4442_CR139","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/jrr\/rraf069","volume":"66","author":"R Sasaki","year":"2025","unstructured":"Sasaki R, Taguchi S, Miyauchi H et al (2025) Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis. J Radiat Res 66(6):707\u2013718","journal-title":"J Radiat Res"},{"issue":"4","key":"4442_CR140","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3857\/roj.2025.00220","volume":"43","author":"MK Ko","year":"2025","unstructured":"Ko MK, Choi KH, Sung W et al (2025) Can lymphocytic toxicity be induced by radiation dose to the bowel bag in whole pelvic radiotherapy? Radiat Oncol J 43(4):181\u2013187","journal-title":"Radiat Oncol J"},{"issue":"2","key":"4442_CR141","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/reveh-2021-0108","volume":"38","author":"SK Meena","year":"2023","unstructured":"Meena SK, Joriya PR, Yadav SM et al (2023) Modulation of radiation-induced intestinal injury by radioprotective agents: a cellular and molecular perspectives. Rev Environ Health 38(2):295\u2013311","journal-title":"Rev Environ Health"},{"issue":"1","key":"4442_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05645-w","volume":"6","author":"H Lu","year":"2023","unstructured":"Lu H, Yan H, Li X et al (2023) Single-cell map of dynamic cellular microenvironment of radiation-induced intestinal injury. Commun Biol 6(1):1248","journal-title":"Commun Biol"},{"key":"4442_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063339","author":"A Jameus","year":"2024","unstructured":"Jameus A, Dougherty J, Narendrula R et al (2024) Acute impacts of ionizing radiation exposure on the gastrointestinal tract and gut microbiome in mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25063339","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4442_CR144","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2350784","volume":"16","author":"K Zheng","year":"2024","unstructured":"Zheng K, Wei Z, Li W (2024) Ecological insights into hematopoiesis regulation: unraveling the influence of gut microbiota. Gut Microbes 16(1):2350784","journal-title":"Gut Microbes"},{"issue":"1","key":"4442_CR145","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/toxsci\/kfz144","volume":"171","author":"X Liu","year":"2019","unstructured":"Liu X, Zhou Y, Wang S et al (2019) Impact of low-dose ionizing radiation on the composition of the gut microbiota of mice. Toxicol Sci 171(1):258\u2013268","journal-title":"Toxicol Sci"},{"issue":"1","key":"4442_CR146","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40168-017-0325-z","volume":"5","author":"D Casero","year":"2017","unstructured":"Casero D, Gill K, Sridharan V et al (2017) Space-type radiation induces multimodal responses in the mouse gut microbiome and metabolome. Microbiome 5(1):105","journal-title":"Microbiome"},{"issue":"3","key":"4442_CR147","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.chom.2014.02.006","volume":"15","author":"A Khosravi","year":"2014","unstructured":"Khosravi A, Y\u00e1\u00f1EZ A, Price JG et al (2014) Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 15(3):374\u2013381","journal-title":"Cell Host Microbe"},{"issue":"8","key":"4442_CR148","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tem.2023.05.006","volume":"34","author":"I Moraitis","year":"2023","unstructured":"Moraitis I, Guiu J, Rubert J (2023) Gut microbiota controlling radiation-induced enteritis and intestinal regeneration. Trends Endocrinol Metab 34(8):489\u2013501","journal-title":"Trends Endocrinol Metab"},{"key":"4442_CR149","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","volume":"157","author":"R Upadhyay","year":"2021","unstructured":"Upadhyay R, Venkatesulu BP, Giridhar P et al (2021) Risk and impact of radiation related lymphopenia in lung cancer: a systematic review and meta-analysis. Radiother Oncol 157:225\u2013233","journal-title":"Radiother Oncol"},{"issue":"1","key":"4442_CR150","doi-asserted-by":"publisher","first-page":"2174721","DOI":"10.1080\/2162402X.2023.2174721","volume":"12","author":"B Palermo","year":"2023","unstructured":"Palermo B, Bottero M, Panetta M et al (2023) Stereotactic ablative radiation therapy in 3 fractions induces a favorable systemic immune cell profiling in prostate cancer patients. Oncoimmunology 12(1):2174721","journal-title":"Oncoimmunology"},{"key":"4442_CR151","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3389\/fonc.2019.01488","volume":"9","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Li T, Chen G et al (2019) Prognosis and risk factors of radiation-induced lymphopenia in early-stage lung cancer treated with stereotactic body radiation therapy. Front Oncol 9:1488","journal-title":"Front Oncol"},{"issue":"2","key":"4442_CR152","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.semradonc.2015.12.002","volume":"26","author":"C Goldsmith","year":"2016","unstructured":"Goldsmith C, Price P, Cross T et al (2016) Dose-volume histogram analysis of stereotactic body radiotherapy treatment of pancreatic cancer: a focus on duodenal dose constraints. Semin Radiat Oncol 26(2):149\u2013156","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"4442_CR153","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.ijrobp.2009.09.075","volume":"78","author":"JD Murphy","year":"2010","unstructured":"Murphy JD, Christman-Skieller C, Kim J et al (2010) A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 78(5):1420\u20131426","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4442_CR154","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41467-022-28744-4","volume":"13","author":"D Zhang","year":"2022","unstructured":"Zhang D, Zhong D, Ouyang J et al (2022) Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy. Nat Commun 13(1):1413","journal-title":"Nat Commun"},{"issue":"4","key":"4442_CR155","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/19490976.2019.1709387","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Dong J, Xiao H et al (2020) Gut commensal derived-valeric acid protects against radiation injuries. Gut Microbes 11(4):789\u2013806","journal-title":"Gut Microbes"},{"issue":"6371","key":"4442_CR156","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, le Chatelier E, Derosa L et al (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359(6371):91\u201397","journal-title":"Science"},{"issue":"3","key":"4442_CR157","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ymthe.2023.01.012","volume":"31","author":"M Uribe-Herranz","year":"2023","unstructured":"Uribe-Herranz M, Beghi S, Ruella M et al (2023) Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy. Mol Ther 31(3):686\u2013700","journal-title":"Mol Ther"},{"issue":"1","key":"4442_CR158","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1172\/JCI124332","volume":"130","author":"M Uribe-Herranz","year":"2020","unstructured":"Uribe-Herranz M, Rafail S, Beghi S et al (2020) Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J Clin Invest 130(1):466\u2013479","journal-title":"J Clin Invest"},{"key":"4442_CR159","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011356","author":"SJ Feigenberg","year":"2025","unstructured":"Feigenberg SJ, Costabile F, Tanes C et al (2025) Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-011356","journal-title":"J Immunother Cancer"},{"key":"4442_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.717636","volume":"11","author":"TS Zhao","year":"2021","unstructured":"Zhao TS, Xie LW, Cai S et al (2021) Dysbiosis of gut microbiota is associated with the progression of radiation-induced intestinal injury and is alleviated by oral compound probiotics in mouse model. Front Cell Infect Microbiol 11:717636","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4442_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188494","volume":"1875","author":"A Badgeley","year":"2021","unstructured":"Badgeley A, Anwar H, Modi K et al (2021) Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives. Biochimica et Biophysica Acta (BBA) Rev Cancer 1875(1):188494","journal-title":"Biochimica et Biophysica Acta (BBA) Rev Cancer"},{"issue":"6","key":"4442_CR162","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/gutjnl-2018-316226","volume":"68","author":"TE Riehl","year":"2019","unstructured":"Riehl TE, Alvarado D, Ee X et al (2019) Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells. Gut 68(6):1003\u20131013","journal-title":"Gut"},{"key":"4442_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618150","volume":"12","author":"C Xia","year":"2021","unstructured":"Xia C, Jiang C, Li W et al (2021) A phase II randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma. Front Immunol 12:618150","journal-title":"Front Immunol"},{"issue":"10","key":"4442_CR164","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.21037\/tlcr-2025-973","volume":"14","author":"Y Du","year":"2025","unstructured":"Du Y, Li Y, Yu M et al (2025) Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study. Transl Lung Cancer Res 14(10):4541\u20134559","journal-title":"Transl Lung Cancer Res"},{"issue":"8","key":"4442_CR165","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy B, Lenehan JG, Miller WH Jr et al (2023) Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med 29(8):2121\u20132132","journal-title":"Nat Med"},{"issue":"8","key":"4442_CR166","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.chom.2024.06.010","volume":"32","author":"Y Kim","year":"2024","unstructured":"Kim Y, Kim G, Kim S et al (2024) Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor. Cell Host Microbe 32(8):1380\u201393.e9","journal-title":"Cell Host Microbe"},{"issue":"1","key":"4442_CR167","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2119055","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang Y, Hong W et al (2022) Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma via STING signaling. Gut Microbes 14(1):2119055","journal-title":"Gut Microbes"},{"issue":"6","key":"4442_CR168","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2011-300367","volume":"61","author":"MA Ciorba","year":"2012","unstructured":"Ciorba MA, Riehl TE, Rao MS et al (2012) Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2\/cyclo-oxygenase-2-dependent manner. Gut 61(6):829\u2013838","journal-title":"Gut"},{"key":"4442_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.617510","volume":"11","author":"WF Stenson","year":"2020","unstructured":"Stenson WF, Ciorba MA (2020) Nonmicrobial activation of TLRs controls intestinal growth, wound repair, and radioprotection. Front Immunol 11:617510","journal-title":"Front Immunol"},{"key":"4442_CR170","doi-asserted-by":"publisher","first-page":"1689735","DOI":"10.3389\/fmicb.2025.1689735","volume":"16","author":"B Wu","year":"2025","unstructured":"Wu B, Zhao A, Chen W et al (2025) Microbiota-mediated modulation of radiosensitivity: mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics. Front Microbiol 16:1689735","journal-title":"Front Microbiol"},{"issue":"10","key":"4442_CR171","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s43018-025-01018-w","volume":"6","author":"J Huang","year":"2025","unstructured":"Huang J, Theelen W, Belcaid Z et al (2025) Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer. Nat Cancer 6(10):1676\u20131692","journal-title":"Nat Cancer"},{"issue":"5","key":"4442_CR172","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","volume":"9","author":"W Theelen","year":"2021","unstructured":"Theelen W, Chen D, Verma V et al (2021) Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Respir Med 9(5):467\u2013475","journal-title":"Lancet Respir Med"},{"key":"4442_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8110461","author":"E Obrador","year":"2020","unstructured":"Obrador E, Salvador R, Villaescusa JI et al (2020) Radioprotection and radiomitigation: from the bench to clinical practice. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines8110461","journal-title":"Biomedicines"},{"issue":"1","key":"4442_CR174","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12951-024-02572-8","volume":"22","author":"C Zheng","year":"2024","unstructured":"Zheng C, Niu M, Kong Y et al (2024) Oral administration of probiotic spore ghosts for efficient attenuation of radiation-induced intestinal injury. J Nanobiotechnology 22(1):303","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"4442_CR175","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/gutjnl-2025-335230","volume":"75","author":"W Wang","year":"2026","unstructured":"Wang W, Yu Y, Wang R et al (2026) Holdemanella biformis augments washed microbiota transplantation for the treatment of radiation enteritis. Gut 75(2):289\u2013301","journal-title":"Gut"},{"issue":"Pt 1","key":"4442_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135757","volume":"280","author":"R Sun","year":"2024","unstructured":"Sun R, Du S, Wang M et al (2024) Colonic long-term retention and colonization of probiotics by double-layer chitosan\/tannic acid coating and microsphere embedding for treatment of ulcerative colitis and radiation enteritis. Int J Biol Macromol 280(Pt 1):135757","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"4442_CR177","doi-asserted-by":"publisher","first-page":"448","DOI":"10.15252\/emmm.201606932","volume":"9","author":"M Cui","year":"2017","unstructured":"Cui M, Xiao H, Li Y et al (2017) Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med 9(4):448\u2013461","journal-title":"EMBO Mol Med"},{"issue":"19","key":"4442_CR178","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3748\/wjg.v30.i19.2603","volume":"30","author":"L Wang","year":"2024","unstructured":"Wang L, Li Y, Zhang YJ et al (2024) Intestinal microecological transplantation for a patient with chronic radiation enteritis: a case report. World J Gastroenterol 30(19):2603\u20132611","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4442_CR179","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nrclinonc.2017.182","volume":"15","author":"D Killock","year":"2018","unstructured":"Killock D (2018) Immunotherapy: gut bacteria modulate responses to PD-1 blockade. Nat Rev Clin Oncol 15(1):6\u20137","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4442_CR180","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","volume":"7","author":"C M\u00e9N\u00e9TRIER-CAUX","year":"2019","unstructured":"M\u00e9N\u00e9TRIER-CAUX C, Ray-Coquard I, Blay JY et al (2019) Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with Cytokines? J Immunother Cancer 7(1):85","journal-title":"J Immunother Cancer"},{"issue":"1","key":"4442_CR181","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","volume":"103","author":"LRG Pike","year":"2019","unstructured":"Pike LRG, Bang A, Mahal BA et al (2019) The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors. Int J Radiat Oncol Biol Phys 103(1):142\u2013151","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4442_CR182","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","volume":"76","author":"L Potters","year":"2010","unstructured":"Potters L, Kavanagh B, Galvin JM et al (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76(2):326\u2013332","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"4442_CR183","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1002\/mp.17181","volume":"51","author":"J Colen","year":"2024","unstructured":"Colen J, Nguyen C, Liyanage SW et al (2024) Predicting radiation-induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy. Med Phys 51(9):6485\u20136500","journal-title":"Med Phys"},{"issue":"18","key":"4442_CR184","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez DR, Tang C, Zhang J et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, Randomized study. J Clin Oncol 37(18):1558\u20131565","journal-title":"J Clin Oncol"},{"issue":"25","key":"4442_CR185","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, Olson R, Harrow S et al (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol 38(25):2830\u20132838","journal-title":"J Clin Oncol"},{"issue":"1","key":"4442_CR186","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar P, Wardak Z, Gerber DE et al (2018) Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 4(1):e173501","journal-title":"JAMA Oncol"},{"issue":"11","key":"4442_CR187","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.70057","volume":"69","author":"LF Tang","year":"2025","unstructured":"Tang LF, Tang FL, Zhou H et al (2025) Bacillus coagulans BC99 protects ionizing radiation-induced intestinal injury and modulates gut microbiota and metabolites in mice. Mol Nutr Food Res 69(11):e70057","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"4442_CR188","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1667\/RADE-23-00189.1","volume":"201","author":"Y Tu","year":"2024","unstructured":"Tu Y, Luo L, Zhou Q et al (2024) Fecal microbiota transplantation repairs radiation enteritis through modulating the gut microbiota-mediated tryptophan metabolism. Radiat Res 201(6):572\u2013585","journal-title":"Radiat Res"},{"issue":"11","key":"4442_CR189","first-page":"3508","volume":"10","author":"T Tian","year":"2020","unstructured":"Tian T, Zhao Y, Yang Y et al (2020) The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation. Am J Cancer Res 10(11):3508\u20133531","journal-title":"Am J Cancer Res"},{"issue":"9237","key":"4442_CR190","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/S0140-6736(00)02787-2","volume":"356","author":"P Vernia","year":"2000","unstructured":"Vernia P, Fracasso PL, Casale V et al (2000) Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet 356(9237):1232\u20131235","journal-title":"Lancet"},{"issue":"1","key":"4442_CR191","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s12672-025-03077-y","volume":"16","author":"CY Ma","year":"2025","unstructured":"Ma CY, Zhao J, Xu XT et al (2025) Predictive biomarkers in the gut microbiome and metabolome for severe acute radiation enteritis in cervical cancer radiotherapy. Discov Oncol 16(1):1220","journal-title":"Discov Oncol"},{"issue":"8","key":"4442_CR192","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3748\/wjg.v29.i8.1344","volume":"29","author":"CY Ma","year":"2023","unstructured":"Ma CY, Zhao J, Gan GH et al (2023) Establishment of a prediction model for severe acute radiation enteritis associated with cervical cancer radiotherapy. World J Gastroenterol 29(8):1344\u20131358","journal-title":"World J Gastroenterol"},{"key":"4442_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1626169","volume":"12","author":"Y Yang","year":"2025","unstructured":"Yang Y, Gu X, Liu C et al (2025) A phase II clinical trial of Bifidobacterium longum subsp. longum BL21 for preventing acute radiation enteritis among pelvic radiotherapy patients. Front Nutr 12:1626169","journal-title":"Front Nutr"},{"issue":"10","key":"4442_CR194","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamaoncol.2025.2361","volume":"11","author":"Z Liao","year":"2025","unstructured":"Liao Z, Xiong X, Zhao L et al (2025) Bacterial decolonization with mupirocin ointment for acute radiation oral mucositis prevention: a phase 3 randomized clinical trial. JAMA Oncol 11(10):1141\u20131149","journal-title":"JAMA Oncol"},{"issue":"7","key":"4442_CR195","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamaoncol.2023.0444","volume":"9","author":"Y Kost","year":"2023","unstructured":"Kost Y, Deutsch A, Mieczkowska K et al (2023) Bacterial decolonization for prevention of radiation dermatitis: a randomized clinical Trial. JAMA Oncol 9(7):940\u2013945","journal-title":"JAMA Oncol"},{"issue":"23","key":"4442_CR196","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1158\/1078-0432.CCR-09-1964","volume":"15","author":"K Kim","year":"2009","unstructured":"Kim K, Pollard JM, Norris AJ et al (2009) High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clin Cancer Res 15(23):7238\u20137245","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4442_CR197","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1515\/raon-2016-0050","volume":"51","author":"T Saito","year":"2017","unstructured":"Saito T, Toya R, Matsuyama T et al (2017) Dosimetric predictors of treatment-related lymphopenia induced by palliative radiotherapy: predictive ability of dose-volume parameters based on body surface contour. Radiol Oncol 51(2):228\u2013234","journal-title":"Radiol Oncol"},{"issue":"5","key":"4442_CR198","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.ijrobp.2023.01.054","volume":"116","author":"L McCullum","year":"2023","unstructured":"McCullum L, Shin J, Xing S et al (2023) Predicting severity of radiation induced lymphopenia in individual proton therapy patients for varying dose rate and fractionation using dynamic 4-dimensional blood flow simulations. Int J Radiat Oncol Biol Phys 116(5):1226\u20131233","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4442_CR199","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.577236","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang Y, Wei K et al (2021) Review: effect of gut microbiota and its metabolite SCFAs on radiation-induced intestinal injury. Front Cell Infect Microbiol 11:577236","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"4442_CR200","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1111\/jcmm.14289","volume":"23","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang Q, Wang X et al (2019) Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy. J Cell Mol Med 23(5):3747\u20133756","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4442_CR201","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.gastro.2025.01.252","volume":"169","author":"I Moraitis","year":"2025","unstructured":"Moraitis I, Taelman J, Arozamena B et al (2025) Mucosal macrophages govern intestinal regeneration in response to injury. Gastroenterology 169(1):119\u201335.e26","journal-title":"Gastroenterology"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04442-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:03:00Z","timestamp":1787223780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04442-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":201,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["4442"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04442-8","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"213"}}